273 related articles for article (PubMed ID: 14561157)
21. Antimicrobial peptides human beta-defensins and cathelicidin LL-37 induce the secretion of a pruritogenic cytokine IL-31 by human mast cells.
Niyonsaba F; Ushio H; Hara M; Yokoi H; Tominaga M; Takamori K; Kajiwara N; Saito H; Nagaoka I; Ogawa H; Okumura K
J Immunol; 2010 Apr; 184(7):3526-34. PubMed ID: 20190140
[TBL] [Abstract][Full Text] [Related]
22. Review: Defensins and cathelicidins in lung immunity.
Tecle T; Tripathi S; Hartshorn KL
Innate Immun; 2010 Jun; 16(3):151-9. PubMed ID: 20418263
[TBL] [Abstract][Full Text] [Related]
23. Cutting edge: mast cell antimicrobial activity is mediated by expression of cathelicidin antimicrobial peptide.
Di Nardo A; Vitiello A; Gallo RL
J Immunol; 2003 Mar; 170(5):2274-8. PubMed ID: 12594247
[TBL] [Abstract][Full Text] [Related]
24. The role of cathelicidins in the innate host defenses of mammals.
Zanetti M
Curr Issues Mol Biol; 2005 Jul; 7(2):179-96. PubMed ID: 16053249
[TBL] [Abstract][Full Text] [Related]
25. IL-10 inhibits while calcitriol reestablishes placental antimicrobial peptides gene expression.
Olmos-Ortiz A; Noyola-Martínez N; Barrera D; Zaga-Clavellina V; Avila E; Halhali A; Biruete B; Larrea F; Díaz L
J Steroid Biochem Mol Biol; 2015 Apr; 148():187-93. PubMed ID: 25088189
[TBL] [Abstract][Full Text] [Related]
26. Protective roles of the skin against infection: implication of naturally occurring human antimicrobial agents beta-defensins, cathelicidin LL-37 and lysozyme.
Niyonsaba F; Ogawa H
J Dermatol Sci; 2005 Dec; 40(3):157-68. PubMed ID: 16150577
[TBL] [Abstract][Full Text] [Related]
27. Structural and functional analysis of the pro-domain of human cathelicidin, LL-37.
Pazgier M; Ericksen B; Ling M; Toth E; Shi J; Li X; Galliher-Beckley A; Lan L; Zou G; Zhan C; Yuan W; Pozharski E; Lu W
Biochemistry; 2013 Mar; 52(9):1547-58. PubMed ID: 23406372
[TBL] [Abstract][Full Text] [Related]
28. Overexpressions of hBD-2, hBD-3, and hCAP18/LL-37 in Gingiva of Diabetics with Periodontitis.
Yılmaz D; Güncü GN; Könönen E; Barış E; Çağlayan F; Gursoy UK
Immunobiology; 2015 Nov; 220(11):1219-26. PubMed ID: 26092093
[TBL] [Abstract][Full Text] [Related]
29. A cathelicidin family of human antibacterial peptide LL-37 induces mast cell chemotaxis.
Niyonsaba F; Iwabuchi K; Someya A; Hirata M; Matsuda H; Ogawa H; Nagaoka I
Immunology; 2002 May; 106(1):20-6. PubMed ID: 11972628
[TBL] [Abstract][Full Text] [Related]
30. Localized antimicrobial peptide expression in human gingiva.
Dale BA; Kimball JR; Krisanaprakornkit S; Roberts F; Robinovitch M; O'Neal R; Valore EV; Ganz T; Anderson GM; Weinberg A
J Periodontal Res; 2001 Oct; 36(5):285-94. PubMed ID: 11585115
[TBL] [Abstract][Full Text] [Related]
31. IL-4 and IL-13 exposure during mucociliary differentiation of bronchial epithelial cells increases antimicrobial activity and expression of antimicrobial peptides.
Zuyderduyn S; Ninaber DK; Schrumpf JA; van Sterkenburg MA; Verhoosel RM; Prins FA; van Wetering S; Rabe KF; Hiemstra PS
Respir Res; 2011 May; 12(1):59. PubMed ID: 21529380
[TBL] [Abstract][Full Text] [Related]
32. Cell differentiation is a key determinant of cathelicidin LL-37/human cationic antimicrobial protein 18 expression by human colon epithelium.
Hase K; Eckmann L; Leopard JD; Varki N; Kagnoff MF
Infect Immun; 2002 Feb; 70(2):953-63. PubMed ID: 11796631
[TBL] [Abstract][Full Text] [Related]
33. The human cathelicidin LL-37: a multifunctional peptide involved in infection and inflammation in the lung.
Tjabringa GS; Rabe KF; Hiemstra PS
Pulm Pharmacol Ther; 2005; 18(5):321-7. PubMed ID: 15939310
[TBL] [Abstract][Full Text] [Related]
34. LL-37, the neutrophil granule- and epithelial cell-derived cathelicidin, utilizes formyl peptide receptor-like 1 (FPRL1) as a receptor to chemoattract human peripheral blood neutrophils, monocytes, and T cells.
De Yang ; Chen Q; Schmidt AP; Anderson GM; Wang JM; Wooters J; Oppenheim JJ; Chertov O
J Exp Med; 2000 Oct; 192(7):1069-74. PubMed ID: 11015447
[TBL] [Abstract][Full Text] [Related]
35. Human defensins and cathelicidins in the skin: beyond direct antimicrobial properties.
Niyonsaba F; Nagaoka I; Ogawa H
Crit Rev Immunol; 2006; 26(6):545-76. PubMed ID: 17341194
[TBL] [Abstract][Full Text] [Related]
36. Defensins and cathelicidins in inflammatory lung disease: beyond antimicrobial activity.
Hiemstra PS
Biochem Soc Trans; 2006 Apr; 34(Pt 2):276-8. PubMed ID: 16545093
[TBL] [Abstract][Full Text] [Related]
37. Expression of defensins in gingiva and their role in periodontal health and disease.
Chung WO; Dommisch H; Yin L; Dale BA
Curr Pharm Des; 2007; 13(30):3073-83. PubMed ID: 17979750
[TBL] [Abstract][Full Text] [Related]
38. Defence molecules in intestinal innate immunity against bacterial infections.
Eckmann L
Curr Opin Gastroenterol; 2005 Mar; 21(2):147-51. PubMed ID: 15711205
[TBL] [Abstract][Full Text] [Related]
39. Human defensins and LL-37 in mucosal immunity.
Doss M; White MR; Tecle T; Hartshorn KL
J Leukoc Biol; 2010 Jan; 87(1):79-92. PubMed ID: 19808939
[TBL] [Abstract][Full Text] [Related]
40. Synergistic actions of antibacterial neutrophil defensins and cathelicidins.
Nagaoka I; Hirota S; Yomogida S; Ohwada A; Hirata M
Inflamm Res; 2000 Feb; 49(2):73-9. PubMed ID: 10738945
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
